JobRx

04/20/2026

Thank you, Rob Wickens!!

04/20/2026

Today’s Tip ...

When Employee Requests Irritate You…

As a leader, your day fills up fast with requests: questions, approvals, asks for feedback and support. Some are easy to handle. Others immediately frustrate you. When that irritation spikes, it’s tempting to blame the volume or the people asking. But the real challenge isn’t the requests themselves—it’s how you interpret and respond to them.

Name the need. Every request carries a deeper longing. Before judging it, ask what’s underlying it: Is it a need for safety, care, belonging, or meaning? Then notice what the request stirs in you. When you identify both, you move from reaction to understanding.

Think of irritation as a cue. Your frustration isn’t random. It’s often tied to what feels threatened in you. Instead of dismissing the request, get specific about your response. Do you feel challenged, drained, excluded, or diminished? The sharper the reaction, the more useful the signal.

Respond with kindness—and conviction. Match your response to the need behind the request. When someone seeks safety, offer clarity without tightening control. When they seek care, provide support without taking over. When they seek belonging, stay open and engaged without forcing agreement. When they seek meaning, clarify growth and opportunity without guarding your own status. Ground yourself first, then respond in a way that addresses the need without overreacting. hbr

04/20/2026

04/20/2026

NACDS Annual Meeting Continuing Coverage

NACDS’ Annual Meeting is fully underway, and DSN has recapped some of the biggest moments.

https://drugstorenews.com/NACDS-Annual-Home-2026?utm_source=swiftmail&utm_medium=email&utm_campaign=DSN_NL_NACDS_Annual&mkt_tok=ODI1LUxTUC01NDUAAAGhRA2IGqvfFJiMRkqpWVY0WcpAPVrFMjzPwWjR2INouliDOKVxbAjONxkin8fvLckfVuNRY-LVM5eTBfGBck8b2yUEtY8RBM8I5lMOH1pyD70e

04/19/2026

Senior Medical Science Liaison, Rare Diseases East, Otsuka Pharmaceutical Co., Ltd.

Advanced degree in Pharmacy, Medicine, Biological Sciences, Health Services Research or Public Health, (PharmD., M.D., PhD. or D.Ph.) is required.
Relevant therapeutic area knowledge is required.
Minimum of 5-7 years related work experience (clinical, health system or industry)

https://jobs.jobrx.com/career/1778593/senior-medical-science-liaison-rare-diseases-east

04/19/2026

Today’s Tip ...

How to Encourage Your Leader to Engage a Coach—Without Undermining Them

For leaders rising through the ranks, honest feedback tends to disappear as their visibility increases, stakes get higher, and people grow more cautious. Over time, even strong executives can develop blind spots without realizing it. If you see this happening, suggesting executive coaching to them can help—but only if you approach it carefully. Your goal is to make it feel like their idea, not your critique.

Diagnose the real barrier. Before you act, identify what’s actually blocking their openness to coaching. Is it ego, where asking for help feels like weakness? A misconception that coaching is remedial? Or is it simply overload? Match your approach to the barrier.

Focus on their pain points. Don’t frame coaching around what they need to fix. Instead, listen for the frustrations they already express. Tie coaching directly to those challenges so it feels like a practical solution, not personal feedback.

Reframe coaching. Position coaching as a tool top performers use to think better, not to improve deficits. Emphasize control: they choose the coach, set the agenda, and keep it confidential. This preserves their authority.

Choose the right messenger. You might not be the best person to deliver this message. Involve trusted peers or advisors when it feels safer and more effective.

Propose a short experiment. Lower the stakes. Suggest a limited trial so they can evaluate value without long-term commitment. hbr

04/19/2026

Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."